Karki B, Sherpa TW, Deo RK, Thapa P. Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal. JPAHS [Internet]. 2024 Jun. 14 [cited 2024 Oct. 31];11(1):21-6. Available from: https://jpahs.edu.np/index.php/jpahs/article/view/369